Juan Andres - MRNA / Moderna, Inc. - Insider Trade Report

Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Juan Andres in MRNA / Moderna, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Juan Andres in MRNA / Moderna, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2022-11-29	814	173.8026	814	173.8026	141,475	345	69.5100	-84,894	-60.01
2022-11-10	192	165.5895	192	165.5895	31,793
2022-08-29	839	135.8126	839	135.8126	113,947
2022-08-10	204	173.6630	204	173.6630	35,427
2022-05-31	749	145.3998	749	145.3998	108,904
2022-05-10	195	133.7138	195	133.7138	26,074
2022-03-01	6,365	152.5250	6,365	152.5250	970,822
2022-02-10	768	158.8920	768	158.8920	122,029

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Transaction History